Reliability and sensitivity of the TonoLab rebound tonometer in awake Brown Norway rats

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 6, 2009, Pages 2802-2808

  Morrison, John C ^a   Jia, Lijun ^a   Cepurna, William ^a   Guo, Ying ^a   Johnson, Elaine ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN NORWAY RAT; CANNULATION; CONTROLLED STUDY; DARKNESS; EXPERIMENTAL RAT; INTERMETHOD COMPARISON; INTRAOCULAR PRESSURE; LIGHT; NONHUMAN; OCULOPLETHYSMOGRAPHY; OPTIC NERVE LESION; PREDICTION; PRESSURE TRANSDUCER; PRIORITY JOURNAL; RAT; READING; RELIABILITY; SENSITIVITY ANALYSIS; ANIMAL; AQUEOUS HUMOR; CALIBRATION; CIRCADIAN RHYTHM; COMPARATIVE STUDY; DARK ADAPTATION; DISEASE MODEL; INSTRUMENTATION; INTRAOCULAR HYPERTENSION; OPTIC NERVE DISEASE; PHYSIOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARD;

ANIMALS; AQUEOUS HUMOR; CALIBRATION; CIRCADIAN RHYTHM; DARK ADAPTATION; DISEASE MODELS, ANIMAL; INTRAOCULAR PRESSURE; OCULAR HYPERTENSION; OPTIC NERVE DISEASES; RATS; RATS, INBRED BN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TONOMETRY, OCULAR;

EID: 66849089088     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2465     Document Type: Article

References (53)

1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-267.
2. Friedman DS, Wolfs RC, O'Colmain BJ, et al. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol. 2004;122:532-538.
3. Drance SM. The Collaborative Normal-Tension Glaucoma Study and some of its lessons. Can J Ophthalmol. 1999;34:1-6.
4. AGIS-Investigators. The Advanced Glaucoma Intervention Study (AGIS), 7: the relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol. 2000;130:429-440.
5. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701-713; discussion 829-730.
6. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268-1279.
7. Gaasterland D, Kupfer C. Experimental glaucoma in the rhesus monkey. Invest Ophthalmol. 1974;13:455-457.
8. Quigley HA, Hohman RM. Laser energy levels for trabecular mesh-work damage in the primate eye. Invest Ophthalmol Vis Sci. 1983;24:1305-1307.
9. Burgoyne CF, Downs JC, Bellezza AJ, Suh JK, Hart RT. The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog Retin Eye Res. 2005;24:39-73.
10. Harwerth RS, Crawford ML, Frishman LJ, Viswanathan S, Smith EL 3rd, Carter-Dawson L. Visual field defects and neural losses from experimental glaucoma. Prog Retin Eye Res. 2002;21:91-125.
11. Harwerth RS, Smith EL 3rd, DeSantis L. Experimental glaucoma: perimetric field defects and intraocular pressure. J Glaucoma. 1997;6:390-401.
12. Morrison JC, Moore CG, Deppmeier LM, Gold BG, Meshul CK, Johnson EC. A rat model of chronic pressure-induced optic nerve damage. Exp Eye Res. 1997;64:85-96.
13. Morrison JC, Johnson EC, Cepurna W, Jia L. Understanding mechanisms of pressure-induced optic nerve damage. Prog Retin Eye Res. 2005;24:217-240.
14. Sawada A, Neufeld AH. Confirmation of the rat model of chronic, moderately elevated intraocular pressure. Exp Eye Res. 1999;69: 525-531.
15. Shareef SR, Garcia-Valenzuela E, Salierno A, Walsh J, Sharma SC. Chronic ocular hypertension following episcleral venous occlusion in rats [letter]. Exp Eye Res. 1995;61:379-382.
16. Levkovitch-Verbin H, Quigley HA, Martin KR, Valenta D, Baumrind LA, Pease ME. Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats. Invest Ophthalmol Vis Sci. 2002;43:402-410.
17. John SW, Anderson MG, Smith RS. Mouse genetics: a tool to help unlock the mechanisms of glaucoma. J Glaucoma. 1999;8:400-412.
18. John SW, Smith RS, Savinova OV, et al. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci. 1998;39:951-962.
19. Aihara M, Lindsey JD, Weinreb RN. Experimental mouse ocular hypertension: establishment of the model. Invest Ophthalmol Vis Sci. 2003;44:4314-4320.
20. Moore CG, Milne ST, Morrison JC. Noninvasive measurement of rat intraocular pressure with the Tono-Pen. Invest Ophthalmol Vis Sci. 1993;34:363-369.
21. Moore CG, Epley D, Milne ST, Morrison JC. Long-term non-invasive measurement of intraocular pressure in the rat eye. Curr Eye Res. 1995;14:711-717.
22. Moore CG, Johnson EC, Morrison JC. Circadian rhythm of intraocular pressure in the rat. Curr Eye Res. 1996;15:185-191.
23. Jia L, Cepurna WO, Johnson EC, Morrison JC. Effect of general anesthetics on IOP in rats with experimental aqueous outflow obstruction. Invest Ophthalmol Vis Sci. 2000;41:3415-3419.
24. Jia L, Cepurna WO, Johnson EC, Morrison JC. Patterns of intraocular pressure elevation after aqueous humor outflow obstruction in rats. Invest Ophthalmol Vis Sci. 2000;41:1380-1385.
25. Ahmed F, Brown KM, Stephan DA, Morrison JC, Johnson EC, Tomarev SI. Microarray analysis of changes in mRNA levels in the rat retina after experimental elevation of intraocular pressure. Invest Ophthalmol Vis Sci. 2004;45:1247-1258.
26. Fortune B, Bui BV, Morrison JC, et al. Selective ganglion cell functional loss in rats with experimental glaucoma. Invest Ophthalmol Vis Sci. 2004;45:1854-1862.
27. Johnson EC, Cepurna WO, Jia L, Morrison JC. The use of cyclodialysis to limit exposure to elevated intraocular pressure in rat glaucoma models. Exp Eye Res. 2006;83:51-60.
28. Pang IH, Johnson EC, Jia L, et al. Evaluation of inducible nitric oxide synthase in glaucomatous optic neuropathy and pressure-induced optic nerve damage. Invest Ophthalmol Vis Sci. 2005;46: 1313-1321.
29. Schlamp CL, Johnson EC, Li Y, Morrison JC, Nickells RW. Changes in Thy1 gene expression associated with damaged retinal ganglion cells. Mol Vis. 2001;7:192-201.
30. Johnson EC, Deppmeier LM, Wentzien SK, Hsu I, Morrison JC. Chronology of optic nerve head and retinal responses to elevated intraocular pressure. Invest Ophthalmol Vis Sci. 2000;41:431-442.
31. Johnson EC, Jia L, Cepurna WO, Doser TA, Morrison JC. Global changes in optic nerve head gene expression after exposure to elevated intraocular pressure in a rat glaucoma model. Invest Ophthalmol Vis Sci. 2007;48:3161-3177.
32. Reitsamer HA, Kiel JW, Harrison JM, Ransom NL, McKinnon SJ. TonoPen measurement of intraocular pressure in mice. Exp Eye Res. 2004;78:799-804.
33. Dalke C, Pleyer U, Graw J. On the use of Tono-Pen XL for the measurement of intraocular pressure in mice. Exp Eye Res. 2005; 80:295-296.
34. Kontiola A. A new electromechanical method for measuring intraocular pressure. Doc Ophthalmol. 1996;93:265-276.
35. Kontiola AI. A new induction-based impact method for measuring intraocular pressure. Acta Ophthalmol Scand. 2000;78:142-145.
36. Goldblum D, Kontiola AI, Mittag T, Chen B, Danias J. Non-invasive determination of intraocular pressure in the rat eye: comparison of an electronic tonometer (TonoPen), and a rebound (impact probe) tonometer. Graefes Arch Clin Exp Ophthalmol. 2002;240:942-946.
37. Kontiola AI, Goldblum D, Mittag T, Danias J. The induction/impact tonometer: a new instrument to measure intraocular pressure in the rat. Exp Eye Res. 2001;73:781-785.
38. Danias J, Kontiola AI, Filippopoulos T, Mittag T. Method for the noninvasive measurement of intraocular pressure in mice. Invest Ophthalmol Vis Sci. 2003;44:1138-1141.
39. Morris CA, Crowston JG, Lindsey JD, Danias J, Weinreb RN. Comparison of invasive and non-invasive tonometry in the mouse. Exp Eye Res. 2006;82:1094-1099.
40. Filippopoulos T, Matsubara A, Danias J, et al. Predictability and limitations of non-invasive murine tonometry: comparison of two devices. Exp Eye Res. 2006;83:194-201.
41. Kontiola A, Puska P. Measuring intraocular pressure with the Pulsair 3000 and Rebound tonometers in elderly patients without an anesthetic. Graefes Arch Clin Exp Ophthalmol. 2004;242:3-7.
42. Wang WH, Millar JC, Pang IH, Wax MB, Clark AF. Noninvasive measurement of rodent intraocular pressure with a rebound tonometer. Invest Ophthalmol Vis Sci. 2005;46:4617-4621.
43. Pease ME, Hammond JC, Quigley HA. Manometric calibration and comparison of TonoLab and TonoPen tonometers in rats with experimental glaucoma and in normal mice. J Glaucoma. 2006; 15:512-519.
44. Neufeld AH, Das S, Vora S, et al. A prodrug of a selective inhibitor of inducible nitric oxide synthase is neuroprotective in the rat model of glaucoma. J Glaucoma. 2002;11:221-225.
45. Grozdanic SD, Betts DM, Sakaguchi DS, Kwon YH, Kardon RH, Sonea IM. Temporary elevation of the intraocular pressure by cauterization of vortex and episcleral veins in rats causes functional deficits in the retina and optic nerve. Exp Eye Res. 2003;77: 27-33.
46. Bui BV, Fortune B. Ganglion cell contributions to the rat full-field electroretinogram. J Physiol. 2004;555:153-173.
47. Danias J, Shen F, Kavalarakis M, et al. Characterization of retinal damage in the episcleral vein cauterization rat glaucoma model. Exp Eye Res. 2006;82:219-228.
48. Hartwick AT, Zhang X, Chauhan BC, Baldridge WH. Functional assessment of glutamate clearance mechanisms in a chronic rat glaucoma model using retinal ganglion cell calcium imaging. J Neurochem. 2005;94:794-807.
49. Huang W, Fileta JB, Dobberfuhl A, et al. Calcineurin cleavage is triggered by elevated intraocular pressure, and calcineurin inhibition blocks retinal ganglion cell death in experimental glaucoma. Proc Natl Acad Sci U S A. 2005;102:12242-12247.
50. Zhou Y, Pernet V, Hauswirth WW, Di Polo A. Activation of the extracellular signal-regulated kinase 1/2 pathway by AAV gene transfer protects retinal ganglion cells in glaucoma. Mol Ther. 2005;12:402-412.
51. Pang IH, Wang WH, Clark AF. Acute effects of glaucoma medications on rat intraocular pressure. Exp Eye Res. 2005;80:207-214.
52. Bui BV, Edmunds B, Cioffi GA, Fortune B. The gradient of retinal functional changes during acute intraocular pressure elevation. Invest Ophthalmol Vis Sci. 2005;46:202-213.
53. He Z, Bui BV, Vingrys AJ. The rate of functional recovery from acute IOP elevation. Invest Ophthalmol Vis Sci. 2006;47:4872-4880.